Revenue Update on MEDNAX Inc(NYSE:MD)

MEDNAX Inc(NYSE:MD) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Jul 28, 2016. Company reported revenue of $771.76M. Analysts estimated a revenue of $775.68M. Earnings per share were $1.03. Analysts had estimated an EPS of $1.07.

MEDNAX Inc (MD) shares turned negative on Thursdays trading session with the shares closing down -0.44 points or -0.65% at a volume of 5,45,585. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $67.19. The peak price level was also seen at $67.19 while the days lowest was $66.51. Finally the shares closed at $66.82. The 52-week high of the shares is $86.09 while the 52-week low is $61.4. According to the latest information available, the market cap of the company is $6,252 M.

Several Insider Transactions has been reported to the SEC. On Jun 14, 2016, Dominic J Andreano (SVP, General Counsel and Secy) sold 3,922 shares at $68.80 per share price.Also, On Jun 10, 2016, Md Carlo A Waldemar, (director) sold 5,334 shares at $70.50 per share price.On Jun 8, 2016, Karl B Wagner (President, Eastern Division) sold 27,482 shares at $68.45 per share price, according to the Form-4 filing with the securities and exchange commission.

MEDNAX Inc. (MEDNAX) is a provider of physician services including newborn maternal-fetal and other pediatric subspecialty care. The Company provides clinical care to babies born prematurely or with complications within specific hospital units primarily neonatal intensive care units (NICUs). It provides anesthesia care at more than 90 hospitals 100 ambulatory surgery centers and office-based practices with over 950 of its affiliated anesthesiologists. It provides acute and chronic pain management services in over 20 pain management centers through its network of physicians and physician assistants. It provides inpatient and office-based clinical care to expectant mothers and their unborn babies through its over 245 affiliated maternal-fetal medicine subspecialists as well as obstetricians and other clinicians. Its network includes other pediatric subspecialists such as pediatric intensivists pediatric hospitalists and pediatric surgeons.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

MEDNAX Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on MEDNAX Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.